EverSource Wealth Advisors
CTNM icon

EverSource Wealth Advisors’s Contineum Therapeutics CTNM Stock Holding History

EverSource Wealth Advisors’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$67 Buy
+5
New +$75 ﹤0.01% 4437
2025
Q4 		– Sell
-48
Closed -$564 – 4480
2025
Q3 		$564 Buy
48
+37
+336% +$298 ﹤0.01% 3920
2025
Q2 		$44 Buy
11
+3
+38% +$13 ﹤0.01% 4202
2025
Q1 		$56 Buy
8
+5
+167% +$45 ﹤0.01% 3890
2024
Q4 		$44 Buy
+3
New +$48 ﹤0.01% 3653

Other funds holding CTNM

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Red Tree Management
Red Tree Management Redwood City, California $117M AUM 89.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

EverSource Wealth Advisors's CTNM Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 5 shares worth $67. The stake represents ﹤0.01% of the portfolio and ranks #4437 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in CTNM as recently as Q3 2025.

EverSource Wealth Advisors first reported a position in CTNM in Q4 2024 and has held it in 5 quarters since. The position peaked at $564 in Q3 2025. 28 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • EverSource Wealth Advisors held 5 shares of Contineum Therapeutics worth $67 as of Q3 2026.
  • Contineum Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4437 holding.
  • EverSource Wealth Advisors first reported a position in Contineum Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's Contineum Therapeutics position peaked at $564 in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.